NumerixS Investment Technologies’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,579
Closed -$84K 695
2020
Q2
$84K Sell
10,579
-845
-7% -$7K 0.02% 645
2020
Q1
$92K Buy
+11,424
New +$136K 0.05% 446
2019
Q3
Sell
-5,754
Closed -$49K 1203
2019
Q2
$49K Sell
5,754
-11,176
-66% -$88.3K 0.01% 776
2019
Q1
$126K Buy
16,930
+3,036
+22% +$24.4K 0.02% 802
2018
Q4
$116K Buy
13,894
+3,500
+34% +$33.5K 0.04% 519
2018
Q3
$101K Buy
10,394
+2,970
+40% +$30.8K 0.02% 803
2018
Q2
$71K Sell
7,424
-10,208
-58% -$100K 0.02% 846
2018
Q1
$169K Buy
17,632
+5,754
+48% +$54.8K 0.04% 466
2017
Q4
$113K Buy
11,878
+1,670
+16% +$16K 0.03% 651
2017
Q3
$106K Sell
10,208
-3,341
-25% -$30.8K 0.02% 737
2017
Q2
$112K Buy
13,549
+5,011
+59% +$37.6K 0.02% 806
2017
Q1
$61K Buy
8,538
+3,156
+59% +$22.9K 0.01% 983
2016
Q4
$38K Buy
5,382
+297
+6% +$2.07K ﹤0.01% 995
2016
Q3
$37K Sell
5,085
-28,212
-85% -$179K ﹤0.01% 985
2016
Q2
$195K Buy
+33,297
New +$221K 0.03% 713

Other funds holding SEM

NumerixS Investment Technologies's SEM Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Select Medical (SEM) in Q3 2020, closing a stake of 10,579 shares — an estimated $84K sold.

NumerixS Investment Technologies first reported a position in SEM in Q2 2016 and held it in 15 quarters. The position peaked at $195K in Q2 2016. 197 funds tracked by Wall St. Rank hold SEM as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Select Medical position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 10,579 Select Medical shares in Q3 2020, an estimated $84K.
  • NumerixS Investment Technologies first reported a position in Select Medical in Q2 2016 and held it in 15 quarters.
  • NumerixS Investment Technologies's Select Medical position peaked at $195K in Q2 2016.
  • 197 funds tracked by Wall St. Rank held Select Medical as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.